Kennedy Capital Management, Inc. Pacira Bio Sciences, Inc. Transaction History

Kennedy Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$29.98 - $46.35 $2.91 Million - $4.5 Million	-97,000 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$31.85 - $46.95 $36,086 - $53,194	-1,133 Reduced 1.15%	97,000 $4.43 Million
Q3 2017 Nov 13, 2017	BUY	$35.7 - $39.5 $3.5 Million - $3.88 Million	98,133	98,133 $3.69 Million

264

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $763M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.